Everlywell launches AI tool to predict breast cancer risk directly to consumers
read at STAT ↗Positive
Everlywell, a digital health company known for offering at-home lab tests, has introduced a new artificial intelligence algorithm that evaluates breast cancer risk from medical images.
The company decided to market the tool straight to patients, bypassing the traditional route of physician or insurer adoption, in order to provide consumers with earlier risk information.
The launch is highlighted in a STAT+ series on how clinical AI tools affect healthcare costs and patient outcomes, underscoring a growing trend toward direct‑to‑consumer health technologies.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients”
read at STAT ↗503 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that